Image Source: Unsplash
 

After opening the day higher, the benchmark indices continued their upward momentum and ended the session in green.

Indian equity market indices Sensex and Nifty settled with gains on Thursday after the US Federal Reserve cut rates by 25 basis points to the 4-4.25 per cent range.

At the closing bell, the BSE Sensex closed higher by 320points (up 0.4%).

Meanwhile, the NSE Nifty closed 93 points higher (up 0.4%).

Eternal, Sun Pharma, and Infosys are among the top gainers today.

Tata Motors, Trent, and Bajaj Finance, on the other hand, were among the top losers today.

The GIFT Nifty was trading at  25,51,4, higher by 100 points at the time of writing.

The BSE MidCap index ended 0.3% higher, and the  BSE SmallCap index ended 0.1% higher.

Sectoral indices are trading mixed today, with stocks in the media sector and the healthcare sector witnessing buying. Meanwhile, stocks in the services sector and the energy sector witnessed selling pressure.

The rupee is trading at Rs 88.1 against the US$.

Gold prices for the latest contract on MCX are trading 0.1% lower at Rs 109,691 per 10 grams.

Meanwhile, silver prices were trading 0.2% higher at Rs 127,243 per 1 kg.
 

Biocon Gets USFDA Nod for Two Biosimilars

In the news from the pharma sector, Biocon's share price jumped after its subsidiary Biocon Biologics received USFDA approval for two biosimilars, Bosaya and Aukelso, which are like Prolia and Xgeva. The USFDA also granted a provisional interchangeability designation for both products.

Bosaya is used to treat osteoporosis in postmenopausal women and men at high risk of fractures, as well as glucocorticoid-induced osteoporosis and bone loss in patients undergoing hormone therapy for prostate or breast cancer.

Aukelso helps prevent bone-related complications in patients with multiple myeloma or bone metastases, treats giant cell tumours of bone, and manages high calcium levels in cancer patients who don't respond to standard treatment.

Clinical trials showed Bosaya and Aukelso are like their reference products in terms of quality, safety, and effectiveness.

Bosaya will have the same safety warnings as Prolia, alerting healthcare providers and patients to the risk of severe calcium deficiency in patients with advanced kidney disease, including those on dialysis.

Biocon is a global biopharmaceutical company that develops and supplies affordable medicines for chronic diseases like diabetes, cancer, and autoimmune disorders.
 

LTIMindtree and Shopify Launch AI Hub

Moving on to the news from IT sector, shares of LTIMindtree came in focus after the company has partnered with Shopify, a leading e-commerce platform, to help businesses launch and grow their online stores. This collaboration combines LTIMindtree's technology expertise with Shopify's AI-powered commerce solutions.

LTIMindtree will establish an AI-enabled Centre of Excellence (CoE) for Digital Commerce using the Shopify platform, assisting multinational corporations in transforming at the speed of AI and innovating at scale.

The company will use Shopify's platform to create an AI-driven Centre of Excellence that will develop advanced AI commerce capabilities, industry-focused accelerators, migration toolkits, and learning programs, and drive co-investments in new integrations and capabilities.

This Centre of Excellence demonstrates the dedication to creating digital commerce that is future-proof and empowering businesses to attain speed, scale, and resilience in a rapidly changing business environment.

LTIMindtree is a global tech consulting firm that helps businesses innovate and grow through digital solutions. With over 700 clients and 83,000 plus professionals, it drives transformation and delivers results in a rapidly changing world.
 

Wage Deal Boosts Hyundai Shares

Moving on to the news from auto sector, shares of Hyundai India surged 3%, following the company's announcement of a long-term wage settlement with the union representing its workers.

A monthly pay increase of Rs 31,000 over three years and increased health benefits for 1,981 employees are part of the wage settlement, which will take effect from 1 April 2024 to 31 March 2027. This demonstrates Hyundai's dedication to worker well-being and a productive workplace.

According to the management of Hyundai Motor India, the company wants to make India a strategic location for manufacturing in developing nations and grow into the biggest export hub for Hyundai outside of South Korea.

Month after month, this goal is gaining significant momentum. In August 2025, the company's exports increased by a remarkable 21% year over year.

More By This Author:

Nifty Above 25,400; Sensex Today Trades Higher
Sensex Today Ends 313 Points Higher; Nifty Above 25,300
Sensex Today Trades Higher; Nifty Above 25,250